New immnotherapy can shrink otherwise untreatable breast, lung and mesothelioma tumors

Researchers at Memorial Sloan Kettering have deveoped the world's first immunotherapy that can shrink treatment-resistant lung, breast and mesothelioma tumors in some two million patients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news